Citação norma APA

Shi, S., Lu, K., Gao, H., Sun, H., & Li, S. (2017). Erlotinib in combination with bevacizumab and FOLFOX4 as second-line chemotherapy for patients with metastatic colorectal cancer. Am J Cancer Res.

Citação norma Chicago

Shi, Sha, Kemei Lu, Hui Gao, Huidong Sun, and Senlin Li. "Erlotinib in Combination With Bevacizumab and FOLFOX4 As Second-line Chemotherapy for Patients With Metastatic Colorectal Cancer." Am J Cancer Res 2017.

Citação norma MLA

Shi, Sha, et al. "Erlotinib in Combination With Bevacizumab and FOLFOX4 As Second-line Chemotherapy for Patients With Metastatic Colorectal Cancer." Am J Cancer Res 2017.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.